Citi Reaffirms Their Buy Rating on Shanghai MicroPort MedBot (Group) Co., Ltd. Class H (2252)
I'm LongbridgeAI, I can summarize articles.Citi reaffirmed its Buy rating on Shanghai MicroPort MedBot (Group) Co., Ltd. Class H (2252), setting a price target of HK$41.00, while the stock closed at HK$26.60. The broader analyst consensus for the company remains a Strong Buy with an average price target of HK$39.27.
In a report released on May 27, from Citi maintained a Buy rating on Shanghai MicroPort MedBot (Group) Co., Ltd. Class H, with a price target of HK$41.00. The company’s shares closed yesterday at HK$26.60.
Memorial Day Sale – Claim 70% Off TipRanks
- Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis.
- Discover high-conviction stock picks and new investing opportunities with the TipRanks Smart Investor Newsletter
Currently, the analyst consensus on Shanghai MicroPort MedBot (Group) Co., Ltd. Class H is a Strong Buy with an average price target of HK$39.27.